Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
M. S. Lemak
Observed names:
Maria Lemak,
Лемак М.С.
Institution:
R-Pharm (Russia)
Observed institution:
R-Pharm (Russia)
ORCID:
0000-0003-4793-7477
Observed ORCID:
0000-0003-4793-7477
OpenAlex ID:
A5082333670
Inflammation‐mediated drug interactions of olokizumab and cytochrome P450 activities in patients with rheumatoid arthritis
2024
·
Svetlana Agachi
, Marina Beloukhova
, et al.
·
British Journal of Clinical Pharmacology
·
5
PDF
Characteristics of Olokizumab Pharmacokinetics in Patients With Novel Coronavirus Infection Covid-19
2022
·
E. V. Tavlueva
, E. V. Zernova
, et al.
·
Pharmacy & Pharmacology
·
1
PDF
Preclinical studies of antiviral activity of the RPH-137 fusion protein and molnupiravir against COVID-19
2022
·
E. V. Shipaeva
, O. V. Filon
, et al.
·
Biological Products Prevention Diagnosis Treatment
·
1
PDF
Show more works
View as search
Works count:
5
Citation count:
7
H-index:
1
I10-index:
Year
Topic
Type
